Maternal Omega Use in pregnancy decreases IL-6 levels in breastmilk


Creative Commons License

Atan Sahın O. N.

Excellence in Pediatrics, Arhus, Denmark, 5 - 07 December 2019, vol.1, no.1, pp.47-48

  • Publication Type: Conference Paper / Full Text
  • Volume: 1
  • City: Arhus
  • Country: Denmark
  • Page Numbers: pp.47-48

Abstract

Anti-inflammatory roperties of LC-PUFA fatty acids DHA and EPA  are very well known in humans. In our study we assessed the interrelationships between breastmilk IL-6, Leptin and breastmilk fattyacids, including PUFAs between women who used omega-3 during pregnancy and who did not, .Lactating women and their babies were involved in the study. Part,c,pants were robustly phenotyped along with their infants at 4-12 weeks postpartum. IL-6, Leptin fatty acids were evaluated by ELISA and GC-FID. IL-6 levels in breastmilk of women who used omega-3 were significantly lower